Display options
Cite
Shibata A, Ohkuma Y, Hayashi T, et al. Efficacy of reduced-fluence photodynamic therapy for serous retinal pigment epithelial detachment with choroidal hyperpermeability. Clin Ophthalmol. 2013;7:2123-6doi: 10.2147/OPTH.S52475.
Shibata, A., Ohkuma, Y., Hayashi, T., & Tsuneoka, H. (2013). Efficacy of reduced-fluence photodynamic therapy for serous retinal pigment epithelial detachment with choroidal hyperpermeability. Clinical ophthalmology (Auckland, N.Z.), 72123-6. https://doi.org/10.2147/OPTH.S52475
Shibata, Asako, et al. "Efficacy of reduced-fluence photodynamic therapy for serous retinal pigment epithelial detachment with choroidal hyperpermeability." Clinical ophthalmology (Auckland, N.Z.) vol. 7 (2013): 2123-6. doi: https://doi.org/10.2147/OPTH.S52475
Shibata A, Ohkuma Y, Hayashi T, Tsuneoka H. Efficacy of reduced-fluence photodynamic therapy for serous retinal pigment epithelial detachment with choroidal hyperpermeability. Clin Ophthalmol. 2013;7:2123-6. doi: 10.2147/OPTH.S52475. Epub 2013 Oct 30. PMID: 24204113; PMCID: PMC3817033.
Copy Download .nbib Format: NLM
Share it on

Clin Ophthalmol. 2013;7:2123-6. doi: 10.2147/OPTH.S52475. Epub 2013 Oct 30.

Efficacy of reduced-fluence photodynamic therapy for serous retinal pigment epithelial detachment with choroidal hyperpermeability.

Clinical ophthalmology (Auckland, N.Z.)

Asako Shibata, Yasuhiro Ohkuma, Takaaki Hayashi, Hiroshi Tsuneoka

Affiliations

  1. Department of Ophthalmology, The Jikei University School of Medicine, Tokyo, Japan.

PMID: 24204113 PMCID: PMC3817033 DOI: 10.2147/OPTH.S52475

Abstract

BACKGROUND: Very few reports have addressed methods of treatment for idiopathic serous (IS) pigment epithelial detachment (PED).

OBJECTIVE: The purpose of this report was to describe clinical courses of two patients with ISPED in whom reduced-fluence photodynamic therapy (RFPDT) was performed.

CASE REPORTS: Two patients (a 38-year-old woman and a 42-year-old man) were diagnosed with ISPED. In both patients, indocyanine green angiography revealed an area of choroidal vascular hyperpermeability including hyperfluorescent PED, which was evident at the subfoveal area. Both patients underwent RFPDT at an energy of 25 J/cm(2). The PED was seen to have resolved 1 month after the treatment and visual acuity was maintained or improved. There was no posttreatment recurrence of PED after 6 months to 1 year, and no treatment-related adverse events were observed.

CONCLUSION: RFPDT may be an effective and safe method of treatment for ISPED with choroidal vascular hyperpermeability.

Keywords: central serous chorioretinopathy; pigment epithelial detachment; reduced-fluence photodynamic therapy

References

  1. Retina. 2003 Dec;23(6):752-63 - PubMed
  2. Arch Ophthalmol. 1978 Apr;96(4):620-4 - PubMed
  3. Retina. 2007 Nov-Dec;27(9):1168-73 - PubMed
  4. Am J Ophthalmol. 2010 Feb;149(2):307-315.e2 - PubMed
  5. Graefes Arch Clin Exp Ophthalmol. 2013 Aug;251(8):1909-17 - PubMed
  6. Br J Ophthalmol. 2003 Dec;87(12):1453-8 - PubMed
  7. Retina. 1997;17(4):286-93 - PubMed
  8. Am J Ophthalmol. 2012 Nov;154(5):865-871.e1 - PubMed
  9. Retina. 2003 Jun;23(3):288-98 - PubMed
  10. Am J Ophthalmol. 1979 Oct;88(4):643-51 - PubMed

Publication Types